Drugs Worth Rs 4.87L Of ESI Hospital Supply Found In A Raid

Hyderabad:  The Telangana Drugs Control Administration (DCA), Karimnagar Zone, raided Srinivasa Medical and General Stores, located in Osmanpura, Karimnagar, and discovered drugs supplied for ESI hospital illegally stocked for sale.

During the raid, five types of drugs labelled ‘ESI SUPPLY NOT FOR SALE’ were seized, with the stock valued at Rs 4.87 lakh. The seized medications included antidiabetic and antiasthmatic drugs, among others.

DG DCA, V Kamalasan Reddy, reported that Dunaboina Murali Rao, a pharmacist grade-II at the ESI dispensary in SPM Colony, Sirpur-Kagaznagar, Kumuram Bheem Asifabad district, had illegally diverted ESI hospital supplies to managing partner of Sri Srinivasa Medical and General Stores, Gampa Krishna, in Karimnagar.

The raid was conducted by the assistant director, Karimnagar, M Srinivasulu, alongside drugs inspectors P Karthik Bharadwaj, T Chandana and P Shravan Kumar, from Karimnagar, Mancherial and Peddapalli.

DCA officers have taken samples for analysis, and further investigation is underway. Legal action will be taken against all offenders in accordance with the law.

Government pharmacists found guilty of illegally diverting hospital supplies are punishable under the Drugs and Cosmetics Act (DCA), with stringent measures promised against such individuals.

Officials warned that the illegal stocking of ESI hospital supply drugs for sale is punishable under the Drugs and Cosmetics Act, with imprisonment of up to two years.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre